Jun Shen

4PUBLICATIONS
9CO-AUTHORS
Time-series analysisRadiation therapyAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 23, 2026
Latent Variable Indirect Response Modeling of Cendakimab Exposure-Response for Longitudinal Dysphagia Days Using a Combined Uniform-Binomial Likelihood Framework.

Shengnan Du, Jessica Wojciechowski, Peijin Zhang

|Aug 18, 2025
Exposure-Response Analysis of Repotrectinib to Support the Dose Recommendation for Patients With ROS1-Positive NSCLC or NTRK-Positive Solid Tumors.

Shengnan Du, Zheyi Hu, Jun Shen

|May 02, 2025
A Novel Empirical Autoinduction Model to Characterize the Population Pharmacokinetics and Recommend Dose for Repotrectinib in Adult and Adolescents With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements.

Shengnan Du, Zheyi Hu, Jun Shen

|Oct 24, 2023
Pediatric model-based dose optimization using a pooled exposure-response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma.

Shengnan Du, Yue Zhao, Zheyi Hu

Pageof 1

Frequent Collaborators

4 joint publications

Shengnan Du

3 joint publications

Lora Hamuro

3 joint publications

Anna Kondic

2 joint publications

Amit Roy